NMPA Approval

Recombinant Cytokine Gene Derived Protein Injection

Approval Number

国药准字S20180002

Registration Date

December 12, 2023

Drug Information

Generic Name

重组细胞因子基因衍生蛋白注射液

Trade Name

乐复能

Brand Name

乐复能

Dosage Form

注射剂

Strength

10μg/1.0 ml/瓶

Drug Type

生物制品

Registration Date

December 12, 2023

Company Address

山东省青岛市崂山区科苑纬三路19号

Company Address

山东省青岛市崂山区科苑纬三路19号

Empowering clinical research with data-driven insights and AI-powered tools.

重组细胞因子基因衍生蛋白注射液 - NMPA 批准文号 | MedPath